Following gene expression screening in lung tumor tissue, especially in NSCLC, it has been shown that both bFGF and FGFR1 and FGFR2 and epidermal growth factor (EGFR) show elevated levels of expression, which thus associates them with an increase in chemotherapy resistance [136]. Here, FGF2 is linked to non-small cell lung carcinoma.